Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Expert Esthetician And CEO Lisa White Of Skin Snatched Joins Exclusive Haute Beauty Network


News Image

“No steps can be skipped when giving a proper facial.”

Skin Snatched is a luxurious skincare boutique located in the heart of Washington, DC, located within the triangle of Kalorama, Dupont Circle, and Adams Morgan. Our salon offers cutting-edge skincare treatments, personalized consultations, chemical peels, micro-needling, and a selection of luxury skincare products from our partner, the esteemed Swiss brand VALMONT.

At Skin Snatched, Lisa White serves as the CEO and Owner. She is a board-certified master esthetician with over twenty-four years of experience in providing specialized luxury skincare services. Her five-star reputation precedes her, as she has cultivated a loyal following for her results-driven facials. Lisa has pampered the skin of A-list celebrities, athletes, dignitaries, politicians, and socialites from around the world. Each facial session with Lisa is an indulgent two-hour experience, as she is dedicated to delivering thorough, ethical, and exceptional results. Her motto is “no steps can be skipped when giving a proper facial,” which reflects her commitment to providing unparalleled skincare services.

Learn more about Skin Snatched by visiting: https://hauteliving.com/hautebeauty/member/skin-snatched/

ABOUT HAUTE BEAUTY NETWORK:

Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.

For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Share article on social media or email:

Bola AI Announces Voice Perio Integration with Open Dental


News Image

Our new integration with Open Dental is consistent with our vision to provide voice-enabled periodontal charting to everyone, regardless of which EHR system they use.

Bola Technologies, Inc. (Bola AI), a leading provider of voice-AI technology for healthcare and dental professionals, continues to expand the availability of its revolutionary Voice Perio system to more dental practices throughout North America. The latest integration available with Bola AI’s innovative technology is with Open Dental.

Bola AI’s Voice Perio system enables dental staff to seamlessly record periodontal data directly into client PMS and EHR systems in real time. It lessens the burden on dentists, hygienists and front-office staff while simultaneously streamlining clinical documentation and administrative duties, including charting, scheduling, imaging, billing, payment processing and much more.

“Our new integration with Open Dental is consistent with our vision to provide voice-enabled periodontal charting to everyone, regardless of which EHR system they use,” said Rushi Ganmukhi, CEO and founder of Bola AI. “Dental practices have asked for this, and customers have been petitioning for greater overall availability of our Voice Perio software. We are pleased to meet the demand by continuing to roll out the availability of our true touchless charting solution to an ever-expanding customer base.”

Open Dental is an open-source dental practice management software provider based out of Oregon.

In recent years, AI and deep learning have made incredible strides, with computer vision, language processing and speech recognition achieving near-human levels. Bola AI’s Voice Perio delivers speech accuracy at 99% and allows for variable accents and flexible phrasing while filtering out background noise and nonclinical speech. One of the things customers appreciate most is how quickly Bola’s voice-charting software responds, with no lagging evident or voice conditioning needed. The system is typically operational on each customer’s platform within 20 minutes. Bola AI offers the first clinical voice assistant for the dental market to utilize this new age of technology while providing unprecedented ease of use and accuracy.

“At Bola AI, our mission is to provide a truly touchless environment that drives efficiency and revenue for dental practices,” said Ganmukhi. “We’re finding that dental practices across the country are ready to embrace the hands-free charting experience our technology offers.”

Bring innovation and cutting-edge AI technology to your dental practice by partnering with Bola AI today.

About Bola AI

With Bola AI, the future of speech artificial intelligence (AI) is here. By harnessing the power of advanced technologies, this platform can provide efficient, fully integrated and accurate speech (99.9%) solutions for periodontal charting, clinical notes and more. With Bola AI, practices can empower themselves to create a smarter patient experience while improving operational efficiency and driving revenue. Partnering with Dentrix and Dentrix Ascend, Curve, Patterson, Overjet and more, Bola is the leader in the voice-charting and notes space. Bola AI is headquartered in Boston, MA. For more information, visit bola.ai.

Share article on social media or email:

Medical Spa Expert Beautique Concierge Joins Exclusive Haute Beauty Network


News Image

Founded by two highly esteemed medical professionals, Dr. Peter Andrade and Dr. Fidel Garcia, Beautique Concierge aims to revolutionize the way patients experience aesthetics and wellness treatments.

Beautique Concierge, a unique aesthetics and wellness brand that offers in-home services and treatments, has officially launched. Founded by two highly esteemed medical professionals, Dr. Peter Andrade and Dr. Fidel Garcia, Beautique Concierge aims to revolutionize the way patients experience aesthetics and wellness treatments.

Beautique Concierge offers the luxury and convenience of in-home services and treatments. No need to commute to a doctor’s office, wait in long lines, or compromise your privacy. The founders, Dr. Andrade and Dr. Garcia, understand the busy lifestyles of their patients and have developed a way to provide quality care from the comfort of their own space.

As a board-certified plastic surgeon, Dr. Andrade brings his expertise in injectables and surgical procedures, while Dr. Garcia, an infusion drip specialist, provides IV treatments to help clients achieve optimal wellness. The duo aims to provide a comprehensive range of services that cater to the needs of their clients. From wrinkle reduction to hydration therapy, Beautique Concierge offers an array of personalized treatments tailored to each client’s unique needs.

Beautique Concierge is committed to providing safe and effective treatments, using only the highest quality products and equipment. Their team of highly trained medical professionals ensures that clients receive the best care possible.

For those looking for a one-of-a-kind treatment experience, Beautique Concierge is the perfect solution. With their in-home services and treatments, clients can enjoy the luxury and convenience of quality care, without ever having to leave their homes.

Learn more about Beautique Concierge by visiting: https://hauteliving.com/hautebeauty/member/beautique-concierge/

ABOUT HAUTE BEAUTY NETWORK:

Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.

For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Share article on social media or email:

Califf’s FDA, 2023 and Beyond Webinar on April 27, 2023


Commissioner Robert Califf has ended his first year as commissioner in the Biden Administration and is now navigating the agency toward his goals: reforms to the product development process, greater reliance on real-world data, more emphasis on orphan drugs and devices, new requirements for accelerated approval drugs, and increased discussion on the role of advisory committees.    

The FDA is in the process of implementing new user fee programs and an enlarged budget authorization. It must also deal with a new Congress and new committee chairs in both the Democratic-controlled Senate and the Republican-controlled House.

Wayne L. Pines, president of healthcare at APCO Worldwide and former associate commissioner of the FDA, along with a panel of experts, will provide a detailed analysis of the latest actions in 2022 under Biden/Califf leadership and insight on what to anticipate in the future. They will focus on practical guidance on how pharmaceutical and medical device manufacturers can adapt to the new FDA.

This webinar will explore what’s happened and what the future may hold at the FDA, including:


  • The post-pandemic adoption of new administrative and personnel practices
  • How the new provisions in the user fee legislation will affect daily business
  • How key personnel changes in the FDA are impacting policy
  • How CDER, CBER, and CDRH are rethinking the research and development process and their own review and approval standards
  • What to expect in terms of emergency authorizations, accelerated approvals, breakthrough and fast-track programs, over-the-counter drug monograph reviews, adaptive trials, and drug importation initiatives
  • Expanded opportunities and staff growth in cell and gene therapy products and regenerative medicine
  • Regulation of AI and software, including digital therapeutics as a medical device
  • Inspection policies and procedures
  • Advertising and promotion policies and enforcement

Webinar Details

Califf’s FDA, 2023 and Beyond

Key Developments, Insights, and Analysis

An FDAnews Webinar Special Edition

Thursday, April 27, 2023, 1:30 p.m.–4:30 p.m. EDT

https://wcg.swoogo.com/caiffs-fda-2023-and-beyond

Tuition:

$337

Easy Ways to Order:

Online: https://wcg.swoogo.com/caiffs-fda-2023-and-beyond

By phone: 888.838.5578 or 703.538.7600

About WCG FDAnews:

WCG FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on WCG FDAnews’ newsletters, books, databases, webinars and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations. Learn more at fdanews.com.

Share article on social media or email:

Vision Expert Dr. Jay Arora Joins Exclusive Haute Beauty Network


News Image

Dr. Jay Arora is an accomplished ophthalmologist with expertise in refractive LASIK surgery, cataract surgery, and glaucoma surgery.

Dr. Jay Arora is an accomplished ophthalmologist with expertise in refractive LASIK surgery, cataract surgery, and glaucoma surgery. He has extensive experience in premium intraocular lens implantation and cataract laser treatment procedures, as well as minor oculoplastics surgical procedures. Dr. Arora is certified in femto-second laser-assisted cataract surgery and minimally invasive glaucoma surgery, and he has a focus on complex refractive and cataract surgical techniques.

Dr. Arora completed his residency and clinical fellowship training in New York City before relocating to the Scottsdale/Phoenix metro area, where he is the owner of Arora Eye, a private practice that consistently receives the highest reviews in patient satisfaction and services provided. At his state-of-the-art facility, he performs outpatient refractive surgeries such as LASIK and PRK, as well as glaucoma laser surgery and post-cataract laser procedures using the most advanced surgical equipment.

Dr. Arora is a Fellow of the American Academy of Ophthalmology and a member of the American Society of Cataract and Refractive Surgery and the Association for Research in Vision and Ophthalmology. He has given several talks and case presentations and is a contributing author of various clinical articles and medical textbooks. He also serves on the Board of Directors for the Maricopa County Medical Society and is a medical expert for HelpMeSee, a charitable organization aimed toward eradicating blindness around the globe.

In addition to his professional achievements, Dr. Arora has been recognized as one of the Top 150 Ophthalmologists in America by Newsweek Magazine. He is highly regarded by his peers for his excellent surgical skills, patient care, and bedside manner. Outside of his practice, Dr. Arora enjoys golf, attending NBA/NFL games, and exploring local sneaker stores.

Learn more about Dr. Jay Arora by visiting: https://hauteliving.com/hautebeauty/member/dr-jay-arora/

ABOUT HAUTE BEAUTY NETWORK:

Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.

For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Share article on social media or email:

Healthcare Privacy Webinar Series Begins Tuesday, April 18


News Image

will introduce the audience to the history of healthcare privacy law and regulation in the United States, and provide an overview of the subsequent four webinars.

Healthcare Privacy Webinar Series Begins Tuesday, April 18

Initial Session Addresses the History of Healthcare Privacy Law to-date

Esteemed healthcare law firm Nelson Hardiman launches its five-part webinar series analyzing the history, progression, and future of healthcare privacy on Tuesday, April 18 beginning at 12 noon PDT.

The series, So, You Thought You Knew Healthcare Privacy…, will be hosted by founding partner Harry Nelson and attorney Adella Katz. The initial session, The Inevitable Implosion of Healthcare Privacy: Understanding Catalysts, Innovation, and Everything in Between, will introduce the audience to the history of healthcare privacy law and regulation in the United States, and provide an overview of the subsequent four webinars. The presentation schedule and registration links follow:

Session One, April 18

The Inevitable Implosion of Healthcare Privacy:

Understanding Catalysts, Innovation, and Everything in Between

https://us02web.zoom.us/webinar/register/WN_xUSBLwl1S4G4XkFdNPrPvg

Session Two, May 16

How We Got Here: HIPAA and 42 CFR Part 2

https://us02web.zoom.us/webinar/register/WN_kznnuUvLRBKwXRfExaGo3g

Session Three, June 13

A New Sheriff in Town: The Groundbreaking Emergence of the FTC in Privacy Enforcement

https://us02web.zoom.us/webinar/register/WN_rZ1pajyNT0Sj0MykWIy7CA

Session Four, July 18

California Calling: How States are Closing the Federal Gap in Consumer Healthcare Privacy

https://us02web.zoom.us/webinar/register/WN_1cqA0lVbSX-1Gr45TNb1SA

Session Five, August 15

The Future of Healthcare Privacy: Projecting What’s Ahead and Planning Next Steps

https://us02web.zoom.us/webinar/register/WN_gO3AOQKDT9SeseOTlx78wA

All sessions begin at 12 noon PDT and will last one hour.

Please join us! To register, visit the links provided above.

About Nelson Hardiman

Nelson Hardiman regularly advises clients on new healthcare law and compliance. The firm offers legal services to businesses at every point in the commercial stream of medicine, healthcare, and the life sciences. For more information, please contact us at nelsonhardiman.com.-

Share article on social media or email:

Seth Gordon Joins PlatformQ Health as General Manager of Digital Solutions


“I’ve had the great fortune of working with industry leading companies and products throughout my career. PlatformQ Health brings such a dedicated and holistic approach to helping physicians, caregivers, and patients get the critical education they need via a best-in-class platform,” said Gordon.

PlatformQ Health is pleased to announce that noted industry leader Seth Gordon has joined the organization in a senior business development and management role, supporting pharmaceutical clients seeking digital solutions to engage and educate healthcare providers and patients online. With 25+ years’ experience crafting award-winning strategies and campaigns, from specialty drugs to blockbusters, including the highly successful statin – Lipitor, Gordon is well positioned to support senior-level industry decision makers looking to optimize digital education for healthcare providers (HCPs) and patients.

“Seth has led work streams across all facets of healthcare, with a significant focus on patient, HCP, and market access strategies,” says PlatformQ Health CEO Robert Rosenbloom. “Additionally, as the child of a surgeon and a nurse, he understands the profound importance of the patient experience. He is the ideal person to guide our growth trajectory as we embark on new digital solution offerings and endeavors.”

Having held numerous leadership positions as well as high-level roles on the consulting side, Gordon has helped dozens of large pharma and emerging biotech clients from pre-launch through the product lifecycle. He joins PlatformQ Health from Eversana, where he served as the general manager of their agency services which focused on HCP, patient and market access work streams for the last four years. Prior to Eversana’s strategic acquisition, he was a managing partner at The Access Group for 13 years, leading the successful growth of the firm’s agency and strategic consulting business into pharma. During his tenure, he managed major agency of record contracts with both large pharma companies and emerging biotechs.

“I am truly excited for this next chapter,” said Seth Gordon. “I have had the great fortune of working with industry leading companies and products throughout my career. PlatformQ Health brings such a dedicated and holistic approach to helping physicians, caregivers, and patients get the critical education they need via a best-in-class platform.

About PlatformQ Health

PlatformQ Health is the leading provider of interactive digital medical education for clinicians, patients, and caregivers. To improve patient care, PlatformQ Health creates video-first educational modules with premier partners, so learners can better understand conditions, available treatment options, and the latest research. The company’s proprietary platform allows participants to engage in real-time discussion with scientific, research, and patient care experts – and the integrated learning solution enables advocates, administrators, health systems and plans, foundations, societies, member organizations, and associations to measure the impact of their education.

Share article on social media or email:

US Fertility supports National Infertility Awareness Week (NIAW) with physician-hosted virtual events and educational resources


US Fertility invites information seekers to free fertility events hosted by US Fertility physicians.

We’re here to provide information and resources when you’re ready to take the next step toward growing your family with fertility treatments.

US Fertility recognizes National Infertility Awareness Week® (NIAW) by hosting free webinars and Instagram Live sessions from April 24 through April 28, 2023, featuring topics important to reproductive health such as the menstrual cycle, fertility preservation, issues affecting male fertility, and infertility treatments.

NIAW is a yearly initiative founded by RESOLVE: The National Infertility Association to encourage people to act as their own infertility advocates and to educate legislators and the public about the impact of infertility within their community. SGF partners with RESOLVE to further its mission of broadening awareness of infertility and supporting those facing infertility with compassionate support and information.

“Support systems, community, and information are such important assets to those facing barriers to growing their families,” shares SGF physician Steven Gay, M.D. “SGF is proud to provide educational events and foster a community for our patients.”    

Throughout the year and especially during NIAW, US Fertility’s partner practices — Fertility Centers of Illinois (FCI), IVF Florida, Reproductive Science Center of the San Francisco Bay Area (RSC), and Shady Grove Fertility (SGF) — seek to empower patients through educational resources, physician-hosted events, and support groups all aimed at taking the fear out of fertility care and empowering patients.

“Infertility affects 1 in 8 couples,” shares FCI physician Jennifer Hirshfeld-Cytron, M.D. “The good news is that there are options to help almost everyone conceive. We’re here to provide information and resources when you’re ready to take the next step toward growing your family with fertility treatments.”

NIAW 2023 US Fertility events at-a-glance:

  • April 24 @ 12 p.m. ET | Menstrual Cycle Webinar | Matthew T. Connell, D.O.
  • April 24 @ 4 p.m. ET | Egg Freezing Instagram Live | Anate Brauer, M.D.
  • April 25 @ 12 p.m. ET | Male Fertility Webinar | Russell Hayden, M.D.
  • April 26 @ 12 p.m. ET | Fertility 101 Webinar | Andrea E. Reh, M.D.
  • April 26 @ 5:30 p.m. CT | Fertility 101: Body & Mind Webinar | Jennifer E. Hirshfeld-Cytron, M.D.
  • April 26 @ 4 p.m. ET | IUI Instagram Live | Phillip A. Romanski, M.D., M.Sc.
  • April 27 @ 12 p.m. MT | IVF Webinar | Cassandra Roeca, M.D.
  • April 28 @ 12 p.m. ET | Donor Egg Webinar | Steven Gay, M.D.
  • April 28 @ 4 p.m. ET | Ask Me Anything Instagram Live | Emily Barnard, D.O.


All webinars and Instagram Live events will allow for a question-and-answer session with the physicians. While US Fertility webinars are complimentary, interested parties must register to attend by visiting the calendar of events. Even if they’re not able to attend the live event, US Fertility encourages attendees to register anyway to receive a follow-up link of the recording.

About US Fertility

US Fertility, the nation’s largest partnership of physician-owned and physician-led top-tier fertility practices, is united under a shared mission: to drive innovation and leverage best practices both to enhance the patient experience and improve treatment outcomes. To date, US Fertility has helped 130,000 babies be born through its fertility services. USF’s collective clinical and operational expertise provides its fertility partner practices with advanced business and digital solutions that streamline and enhance the delivery of exceptional patient care.

Share article on social media or email:

Scientists Create Most Powerful, Accurate Tool Yet to Research Deadliest Blood Cancer


“Our new models are groundbreaking tools that can uniquely empower leukemia research,” said Eirini Papapetrou, MD, PhD, of The Tisch Cancer Institute.

Tisch Cancer Center scientists have developed unique models of the deadliest blood cancer, acute myeloid leukemia (AML), creating a transformative resource to study this cancer and eventually its drug response and drug resistance. The models were described in a late-breaking abstract at the annual meeting of the American Association of Cancer Research and simultaneously published in Blood Cancer Discovery, a journal of the American Association for Cancer Research.

These are the first powerful models that are nearly identical to AML found in patients. The researchers said these models represent the disease accurately in genetic composition and in disease characteristics found in laboratory cell cultures, animal models, and patients.

AML is a fast-growing cancer with only a 29 percent survival rate. It has often already spread widely in the bone marrow and blood by the time it’s first discovered in a patient, so being able to study the cancer, its progression, and its response to drugs in accurate and viable cell lines is crucial.

“We show that these models are nearly identical to the leukemias of the patients that they came from and thus are faithful models for acute myeloid leukemia,” said senior author Eirini Papapetrou, MD, PhD, Professor of Oncological Sciences, and Medicine (Hematology and Medical Oncology), at The Tisch Cancer Institute, part of the Tisch Cancer Center, and Director of the Center for Advancement of Blood Cancer Therapies (CABCT) at the Institute for Regenerative Medicine at the Icahn School of Medicine at Mount Sinai. “Animal models do not provide accurate genetic models of AML, AML cells from the bone marrow or blood survive poorly outside of the body, and AML cell lines carry many additional genetic and karyotypic abnormalities that make them distinct from primary tumors. Our new models are groundbreaking tools that can uniquely empower leukemia research.”

To create these models, researchers used genetic reprogramming technology to convert blood or bone marrow cells from 15 patients representing all major genetic groups of AML to a particular type of stem cells (called induced pluripotent stem cells) that can mimic different stages of disease progression, from a healthy state to pre-malignancy and finally full-blown leukemia. Importantly, the leukemia cells derived from these lines can be transplanted into animal models and create a disease remarkably similar to that seen in the patients.

Many of these lines have been distributed to other researchers, who, along with Dr. Papapetrou and her colleagues, will pursue a number of new studies into leukemia pathogenesis and drug responses. A commentary on the significance of Dr. Papapetrou’s journal article in Blood Cancer Discovery explains how the study advances the field, both practically and conceptually.

“The large panel of genetically defined iPSC clones . . . are versatile disease models and important resources for the community,” the commentary, written by Sergei Doulatov, PhD, Associate Professor of Hematology at the University of Washington, says. “This study dispels the notion that leukemias are difficult or impossible to reprogram.”

About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report’s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

Akkadian Labs and Mobile Heartbeat Announce Technology Partnership


Akkadian provisions Mobile Heartbeat users

Akkadian provisions Mobile Heartbeat users

“We are excited to be working with Mobile Heartbeat. With 50% of the top hospitals in the U.S. already using Akkadian Provisioning Manager, we envision numerous joint customers benefiting from this technology partnership” said Tom Bamert, Chief Product Officer at Akkadian Labs.

Akkadian Labs, developer of the leading unified communications (UC) provisioning automation solution for enterprises and MSPs, is pleased to announce a new partnership with Mobile Heartbeat, the leading clinical communications and collaboration platform for the healthcare enterprise. Our flagship product, Akkadian Provisioning Manager, now integrates with Mobile Heartbeat’s MH-CURE® clinical communication and collaboration platform — allowing zero-touch provisioning of Mobile Heartbeat users.

“We are excited to be working with Mobile Heartbeat. With 50% of the top hospitals in the U.S. already using Akkadian Provisioning Manager, we envision numerous joint customers benefiting from this technology partnership” said Tom Bamert, Chief Product Officer at Akkadian Labs.

Users of MH-CURE are automatically provisioned with the API Triggers feature, streamlining UC workflows. For example, after on-boarding a new user into the Cisco Collaboration UC platform, Provisioning Manager can be configured to add a MH-CURE account for the new employee – saving time, reducing costs, and assuring consistency.

This technology partnership between Akkadian Labs and Mobile Heartbeat enables the healthcare enterprise to seamlessly manage MACD’s for a variety of communications and collaboration solutions, allowing the UC administrator to focus on strategic projects rather than repetitive, manual tasks. “By integrating Mobile Heartbeat’s MH-CURE with Akkadian Provisioning Manager we’re allowing IT teams, project managers, and administrators to efficiently manage user access to key collaboration solutions across the healthcare enterprise” said Mobile Heartbeat Chief Operating Officer, Mike Detjen. “Interoperability across the ecosystem, which ultimately helps care teams access the tools necessary to deliver patient care is our goal”.

The Akkadian Provisioning Manager integration with Mobile Heartbeat’s MH-CURE is currently deployed at one of the largest healthcare networks in the American Southwest.

About Akkadian Labs

Akkadian Labs helps enterprises streamline user provisioning for unified communications. Our automated UC provisioning software helps turn manual, error-prone provisioning tasks into streamlined, repeatable steps that anyone can perform. Businesses and MSPs trust Akkadian Labs to make their UC platforms more efficient, cost-effective, and easier to manage.

To learn more about Akkadian Labs, visit the website or schedule a demonstration today to see Akkadian Provisioning Manager in action.

About Mobile Heartbeat

Mobile Heartbeat® is a leading clinical communication and collaboration company with the goal of driving collaborative care and positive patient outcomes throughout the healthcare enterprise. Using a single, highly integrated clinical communication platform, MH-CURE® securely engages colleagues across every department. Our solution quickly finds the right person at the right time with the right information on the right patient to collaborate on the right care resulting in accelerated decision-making, improved care delivery, and faster patient throughput. Hundreds of thousands of nurses, physicians, and allied health workers at the largest, most complex healthcare systems in the United States rely on Mobile Heartbeat to power their communications.

Click here to learn more about Mobile Heartbeat

###

Share article on social media or email: